chronic lymphocytic leukemia

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
Nyla A. Heerema, Natarajan Muthusamy, Qiuhong Zhao, Amy S. Ruppert, Heather Breidenbach, Leslie A. Andritsos, Michael R. Grever, Kami J. Maddocks, Jennifer Woyach, Farrukh Awan, Meixiao Long, Amber Gordon, Caitlin Coombes, John C. Byrd

Haematologica May 2020, haematol.2018.212571; DOI: 10.3324/haematol.2018.212571
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers
Thomas Lewis, David B. Corcoran, David E. Thurston, Peter J. Giles, Kevin Ashelford, Elisabeth J. Walsby, Christopher D. Fegan, Andrea G.S. Pepper, Khondaker Miraz Rahman, Chris Pepper

Haematologica May 2020, haematol.2019.238584; DOI: 10.3324/haematol.2019.238584
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia
Francesca Arruga, Sara Serra, Nicoletta Vitale, Giulia Guerra, Andrea Papait, Benjamin Baffour Gyau, Francesco Tito, Dimitar Efremov, Tiziana Vaisitti, Silvia Deaglio

Haematologica Apr 2020, haematol.2019.242016; DOI: 10.3324/haematol.2019.242016
Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
Lesley-Ann Sutton, Viktor Ljungström, Anna Enjuanes, Diego Cortese, Aron Skaftason, Eugen Tausch, Katerina Stano Kozubik, Ferran Nadeu, Marine Armand, Jikta Malcikova, Tatjana Pandzic, Jade Forster, Zadie Davis, David Oscier, Davide Rossi, Paolo Ghia, Jonathan C. Strefford, Sarka Pospisilova, Stephan Stilgenbauer, Frederic Davi, Elias Campo, Kostas Stamatopoulos, Richard Rosenquist, European Research Initiative on CLL (ERIC)

Haematologica Apr 2020, haematol.2019.234716; DOI: 10.3324/haematol.2019.234716
FcγRIIb-BCR co-ligation inhibits BCR signaling in chronic lymphocytic leukemia
Rosa Bosch, Alba Mora, Carolina Cuellar, Gerardo Ferrer, Sergey Gorlatov, Josep Nomdedéu, Emili Montserrat, Jorge Sierra, Kanti R. Rai, Nicholas Chiorazzi, Carol Moreno

Haematologica Mar 2020, haematol.2019.245795; DOI: 10.3324/haematol.2019.245795
Stem cell factor Is implicated In microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia
George I. Gavriilidis, Stavroula Ntoufa, Nikos Papakonstantinou, Konstantia Kotta, Triantafyllia Koletsa, Elisavet Chartomatsidou, Theodoros Moysiadis, Niki Stavroyianni, Achilles Anagnostopoulos, Eleni Papadaki, Asterios S. Tsiftsoglou, Kostas Stamatopoulos

Haematologica Mar 2020, haematol.2019.236513; DOI: 10.3324/haematol.2019.236513
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice
Bola S. Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, Philipp M. Roessner, Ralph Schulz, Peter Lichter, Stephan Stilgenbauer, Martina Seiffert

Haematologica Mar 2020, haematol.2019.238154; DOI: 10.3324/haematol.2019.238154
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicentre, open-label phase-II trial
Paula Cramer, Julia v. Tresckow, Sandra Robrecht, Jasmin Bahlo, Moritz Fürstenau, Petra Langerbeins, Natali Pflug, Othman Al-Sawaf, Werner J. Heinz, Ursula Vehling-Kaiser, Jan Dürig, Eugen Tausch, Manfred Hensel, Stephanie Sasse, Anna-Maria Fink, Kirsten Fischer, Karl-Anton Kreuzer, Sebastian Böttcher, Matthias Ritgen, Michael Kneba, Clemens-Martin Wendtner, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek

Haematologica Feb 2020, haematol.2019.223693; DOI: 10.3324/haematol.2019.223693
Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation
Maria Tsagiopoulou, Vicente Chapaprieta, Martí Duran-Ferrer, Theodoros Moysiadis, Fotis Psomopoulos, Panagoula Kollia, Nikos Papakonstantinou, Elias Campo, Kostas Stamatopoulos, Jose I. Martin-Subero

Haematologica Feb 2020, haematol.2019.240721; DOI: 10.3324/haematol.2019.240721
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia
Toby A. Eyre, Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, Bruce D. Cheson, Maryam Yazdy, John N. Allan, Joanna Rhodes, Stephen J. Schuster, Chadi Nabhan, Alan Skarbnik, Lori Leslie, Prioty Islam, Katherine Whitaker, Catherine C. Coombs, Hande H. Tuncer, John M. Pagel, Ryan Jacobs, Allison M. Winter, Neil Bailey, Andrea Sitlinger, Anna H. Schuh, George Follows, Christopher P. Fox, Danielle M. Brander, Mazyar Shadman, Anthony R. Mato

Haematologica Feb 2020, haematol.2019.241539; DOI: 10.3324/haematol.2019.241539

chronic lymphocytic leukemia

Pages